CGC
Price
$1.10
Change
-$0.09 (-7.56%)
Updated
Nov 13 closing price
Capitalization
373.69M
84 days until earnings call
Intraday BUY SELL Signals
SBFM
Price
$1.67
Change
-$0.10 (-5.65%)
Updated
Nov 13 closing price
Capitalization
8.24M
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGC vs SBFM

Header iconCGC vs SBFM Comparison
Open Charts CGC vs SBFMBanner chart's image
Canopy Growth
Price$1.10
Change-$0.09 (-7.56%)
Volume$24.07M
Capitalization373.69M
Sunshine Biopharma
Price$1.67
Change-$0.10 (-5.65%)
Volume$104.77K
Capitalization8.24M
CGC vs SBFM Comparison Chart in %
View a ticker or compare two or three
VS
CGC vs. SBFM commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and SBFM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CGC: $1.19 vs. SBFM: $1.77)
Brand notoriety: CGC: Notable vs. SBFM: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 91% vs. SBFM: 4%
Market capitalization -- CGC: $373.69M vs. SBFM: $8.24M
CGC [@Pharmaceuticals: Generic] is valued at $373.69M. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $8.24M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, SBFM is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while SBFM’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 7 bearish.
  • SBFM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SBFM is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а +4.39% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.08%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +32.16%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2026.

SBFM is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($374M) has a higher market cap than SBFM($8.24M). SBFM YTD gains are higher at: -41.000 vs. CGC (-56.569). SBFM has higher annual earnings (EBITDA): -6.19M vs. CGC (-410.31M). CGC has more cash in the bank: 144M vs. SBFM (10.3M). SBFM has less debt than CGC: SBFM (929K) vs CGC (328M). CGC has higher revenues than SBFM: CGC (275M) vs SBFM (36.3M).
CGCSBFMCGC / SBFM
Capitalization374M8.24M4,538%
EBITDA-410.31M-6.19M6,625%
Gain YTD-56.569-41.000138%
P/E RatioN/A0.00-
Revenue275M36.3M758%
Total Cash144M10.3M1,398%
Total Debt328M929K35,307%
FUNDAMENTALS RATINGS
CGC vs SBFM: Fundamental Ratings
CGC
SBFM
OUTLOOK RATING
1..100
6085
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
8746
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
n/a26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (43) in the null industry is somewhat better than the same rating for CGC (94) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew somewhat faster than CGC’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to CGC’s over the last 12 months.

SBFM's SMR Rating (95) in the null industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to CGC’s over the last 12 months.

SBFM's Price Growth Rating (46) in the null industry is somewhat better than the same rating for CGC (87) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew somewhat faster than CGC’s over the last 12 months.

SBFM's P/E Growth Rating (81) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCSBFM
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signal:
Gain/Loss:
SBFM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTHR461.542.33
+0.51%
United Therapeutics Corp
LIDR2.480.01
+0.40%
AEye
CPAC7.23-0.03
-0.41%
Cementos Pacasmayo SAA
CBZ52.01-0.40
-0.76%
CBIZ
TPET1.00-0.02
-1.96%
Trio Petroleum Corp

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-0.83%
SNDL - CGC
77%
Closely correlated
-3.24%
ACB - CGC
66%
Loosely correlated
-0.44%
TLRY - CGC
63%
Loosely correlated
-4.65%
OGI - CGC
61%
Loosely correlated
-1.83%
CRON - CGC
58%
Loosely correlated
+0.79%
More

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and OGI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
+1.14%
OGI - SBFM
25%
Poorly correlated
-1.83%
ELAN - SBFM
23%
Poorly correlated
-3.54%
NBIX - SBFM
23%
Poorly correlated
-0.30%
AQST - SBFM
23%
Poorly correlated
-1.93%
CGC - SBFM
22%
Poorly correlated
-0.83%
More